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Angiogenesisolyzes phosphatidylcholine to generate phosphatidic acid and choline. Studies in
cultured cells and Drosophila melanogaster have implicated PLD in the regulation of many cellular functions,
including intracellular vesicle trafﬁcking, cell proliferation and differentiation. However, the function of PLD
in vertebrate development has not been explored. Here we report cloning and characterization of a zebraﬁsh
PLD1 (pld1) homolog. Like mammalian PLDs, zebraﬁsh Pld1 contains two conservative HKD motifs.
Maternally contributed pld1 transcripts are uniformly distributed in early embryo. Localized expression of
pld1 is observed in the notochord during early segmentation, in the somites during later segmentation
and in the liver at the larval stages. Studies in intact and cell-free preparations demonstrate evolutionary
conservation of regulation. Inhibition of Pld1 expression using antisense morpholino oligonucleotides (MO)
interfering with the translation or splicing of pld1 impaired intersegmental vessel (ISV) development.
Incubating embryos with 1-butanol, which diverts production of phosphatidic acid to a phosphatidylalcohol,
caused similar ISV defects. To determine where Pld1 is required for ISV development we performed
transplantation experiments. Analyses of the mosaic Pld1 deﬁcient embryos showed partial suppression of
ISV defects in the segments containing transplanted wild-type notochord cells but not in the ones containing
wild-type somitic cells. These results provide the ﬁrst evidence that function of Pld1 in the developing
notochord is essential for vascular development in vertebrates.
© 2009 Elsevier Inc. All rights reserved.Introduction
Phospholipase D (PLD) catalyzes the hydrolysis of phosphatidyl-
choline (PC) to generate phosphatidic acid (PA) and choline. PA and its
metabolites, diacylglycerol (DAG) and lysophosphatidic acid (LPA),
participate in multiple cellular activities, including intracellular
vesicle trafﬁcking, endocytosis, secretion, cell proliferation, differen-
tiation, migration, and survival (Jenkins and Frohman, 2005; McDer-
mott et al., 2004). In the presence of primary alcohols, PLD catalyzes a
transphosphatidylation reaction to generate phosphatidylalcohols
with high efﬁciency (Morris et al., 1997; Yang et al., 1967). This
attribute has been utilized to track the activity of PLD in cells. Two
mammalian genes encoding PLD, PLD1 and PLD2, have been identiﬁedgy, 442 RRB, Vanderbilt Uni-
ashville, TN 37232-6600, USA.
own).
l rights reserved.and characterized. Both PLD enzymes require phosphatidylinositol
4,5-bisphosphate (PIP2) as a cofactor. However, PLD1 and PLD2 exhibit
quite different regulatory properties and subcellular localization. PLD1
has a low basal activity and is activated by small G proteins (ARF, Rho
and Rac) and PKC, whereas PLD2 is constitutively active, and
insensitive to PLD1 activators in vitro (Colley et al., 1997; Hammond
et al., 1995). Subcellular fractionation and immunocytochemistry
studies suggest that PLD1 is localized in intracellular membranes and
vesicular compartments, including Golgi, endosomes, lysosomes, and
secretory granules. By contrast, PLD2 is associated with plasma
membrane. PLD activation has been implicated in the actions of a
number of growth factors, cytokines, hormones and neurotransmit-
ters, including those that activate both heterotrimeric G protein-
coupled receptors and receptor tyrosine kinases (Brown et al., 2007;
Buchanan et al., 2005; Exton, 2002; Zhao et al., 2007). More recently,
PLD was implicated in the regulation of neurite outgrowth (Cai et al.,
2006; Watanabe et al., 2004). By analyzing Drosophila melanogaster
mutants deﬁcient in a pld homolog, Lalonde and collaborators recently
suggested that PLD participates in phototransduction by maintaining
an adequate level of PIP2 (LaLonde et al., 2005). Due to the difﬁculty of
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model systems, most of the studies have been conducted at the
cellular level using biochemical approaches. Therefore, the function of
PLD in vertebrate embryogenesis remains undeﬁned.
Partial cloning of a zebraﬁsh gene encoding Pld1 homolog (amino
acids 380–916), and its expression pattern during gastrulation stages
was previously reported (Ghosh et al., 2003). However the develop-
mental role of Pld1 was not directly investigated. In this study, we
cloned a full-length cDNA encoding the zebraﬁsh Pld1 homolog and
demonstrated that it is expressed maternally and in ubiquitous
fashion at blastula stages, but at a very low level during gastrulation.
Later pld1 transcripts are conﬁned to the notochord during early
segmentation stages, to the somites during later segmentation, and
are detected in the liver at larval stages. Blocking Pld1 function with
antisense morpholino oligonucleotides (MO), designed to interfere
with either pld1 RNA translation or splicing, impaired the formation
of intersegmental vessels (ISV). Embryos incubated with 1-butanol
(0.3%), which diverts the production of phosphatidic acid, exhibited
similar ISV defects. Transplantation experiments support the notion
that Pld1 promotes ISV development in non-autonomous fashion.
The ISV defects were partially restored in pld1 deﬁcient chimeric
embryos containing transplanted wild-type cells in their notochord
but not somites. This ﬁrst study of loss of Pld1 function in a
vertebrate organism reveals an essential role for PLD in the vascular
development.
Methods and materials
Cloning of zebraﬁsh pld1 and RT-PCR
Four zebraﬁsh-expressed sequence tag (EST) clones (GenBank
accession numbers: CK237875, CK029229, CD590334 and CF997495)
encoding protein fragments with sequence similarity to human PLD1
were identiﬁed using NCBI tblastn. The 5′- and 3′-UTR regions of
zebraﬁsh pld1 were determined by 5′- and 3′-RACE PCR (Clontech),
respectively. The total RNA from 2 dpf embryos was isolated using
Trizol® reagent (Invitrogen). SuperScript™ First-Strand Synthesis
System for RT-PCR (Invitrogen) was used to synthesize cDNAs. The
full length ORF of zebraﬁsh pld1was ampliﬁed by PCR using a forward
primer (5′-CACCATGAGTGATTCGGTGGAGAACCTGGACACC-3′) and a
reverse primer (5′-TCAGGTCCAGATCTCGGTGGGCACCA-3′). The
resulting PCR product was directly cloned into pENTR™/SD/D-
TOPO® entry vector by Gateway® BP recombination reaction (Invitro-
gen). Subsequently, pld1 ORF was transferred into pCS2 destination
vector (a gift from Lawson lab) for in vitro transcription. Sequencing of
the resulting plasmids conﬁrmed the zebraﬁsh pld1 ORF and the
deduced amino acid sequences of the pld1 ORF match those in the
GenBank database with the exception of M116L and I503M.
To measure the zebraﬁsh Pld1 activity in mammalian cells, the
pld1 ORF was ampliﬁed by PCR using a forward primer (5′-AACTG-
CAGTCACCATGAGTGATTCGGTG-3′) and a reverse primer (5′-GGGG-
TACCTCAGGTCCAGATCTCGGTG-3′) and the PCR product was
subcloned into the Pst1 and Kpn1 sites of pEGFP-C1 vector (Clontech).
The catalytic inactive mutant K846R was generated by a point
mutation in the 2nd HKD motif using Quick Change II Site-directed
mutagenesis kit (Stratagene). The resulting mutation was conﬁrmed
by sequencing.
The total RNA from control or antisense morpholino oligonucleo-
tides (MOs) injected embryos was isolated using Trizol® reagent
(Invitrogen). The ﬁrst strand cDNAs were synthesized using Thermo-
script RT-PCR System (Invitrogen) according to the manufacturer's
instructions. pld1 cDNAwas then ampliﬁed using the ﬁrst strand cDNA.
The following primers were used in the PCR reactions: forward primer
1: 5′-GCAGACATGAGTGATTCGGT-3′; forward primer 2: 5′-CTGAGCCCT-
GAGATCTTTCTGA-3′; reverse primer 1: 5′-TCTTGACAAAGGCTGGA-
TAGT-3′; reverse primer 2: CTCCCACTCCTGTCTGAAGACT-3′.Measurement of Pld activity in vivo and in vitro
TREx HEK293 cells were plated at 5×105 cells/well on poly-L-
lysine coated 6-well plates the day before transfection. Cells were
transfected with vectors encoding hPLD1 wt, hPLD1 K898R, zPld1 wt,
zPld1 K846R, or pEGFP-C1 vector alone (Clontech) using Lipofecta-
mine 2000 (Invitrogen) according to the manufacturer's instruction.
All of the PLD1 expression plasmids were cloned in pEGFP-C1 vector.
To measure PLD activity in vivo, 30 h after transfection, cells were
radiolabeled with 3H-18:1 fatty acid in the serum free medium for
18 h. The majority of the label is incorporated as phosphatidylcholine,
which is the major substrate of PLD. After removing the labeling
medium, cells were treatedwith either vehicle (basal) or 100 nM PMA
(phorbol ester) for 30 min in the presence of 0.3% 1-butanol at 37 °C.
The assays were conducted as described (Brown et al., 2007; Henage
et al., 2006). The in vitro assay is a well-established biochemical assay
(Brown et al., 1993) used tomeasure PLD activity in reconstituted lipid
vesicles. The details for making the lipid vesicles, puriﬁcation of
recombinant proteins, and measurements of kinetic parameters are
described in detail in Brown et al. (2007).
The analysis of lipids by mass spectrometry was performed
essentially as previously described. Lipids were extracted from
zebraﬁsh embryos, prepared for mass spectrometry analysis, and
statistically analyzed as detailed in Ivanova et al. (2007). The
references and examples of lipid fragmentation used to identify
molecular species can be found (along with downloads of relevant
methods chapters) at http://www.lipidmaps.org/.
Zebraﬁsh strains and maintenance and chemical treatment
The AB⁎ and TLWT zebraﬁsh strains were maintained as described
(Solnica-Krezel et al., 1994). Embryos were obtained from natural
spawnings and staged according tomorphology as described (Kimmel
et al., 1995). A transgenic line expressing green ﬂuorescent protein
(GFP) under the control of the ﬂk-1 promoter TG(ﬂk1:GFP) was
described by Cross et al. (2003). A transgenic line expressing green
ﬂuorescent protein (GFP) under the control of the ﬂi-1 promoter TG
(ﬂi1:GFP) was described by Lawson and Weinstein (2002). To inhibit
PLD signaling, embryos were incubated with embryo media contain-
ing 0.3% 1-butanol or t-butanol at the indicated stages.
In vitro transcription and translation
In vitro transcription and translation of zebraﬁsh Pld1 was
performed by using the TNT Quick Coupled Reticulocyte Lysate
system (Promega), according to the manufacturer's protocol. 0.5 μg
ﬂag-Pld1-pCS2 and various amount of MO1-pld1 (0, 10 nM, 0.5 μM,
and 5 μM) were added for each 25 μl reaction. The reactions were
incubated at 30 °C for 90 min. 6 μl of the reaction samples was
denatured, loaded and separated on 8% SDS-PAGE gel and transferred
to Immuno-P membrane. The synthesized zebraﬁsh Pld1 protein was
detected by anti-ﬂag antibody.
Whole mount in situ hybridization, sectioning, immunostaining
and microscopy
Whole mount in situ hybridization was performed as described
previously (Thisse et al., 1993). pld1 antisense digoxigen-labeled in
situ probe was synthesized using T7 RNA polymerase (Ambion) and
precipitated with LiCl and EtOH and re-suspended in RNAase free
water. Probe quantity was measured by spectro-photometry and
quality was assayed using gel electrophoresis. Photographs of
embryos were captured with a Zeiss Discovery V.12 microscope
equipped with an Axiocam digital camera. For histological sections,
the embryos processed by in situ hybridizationwere embedded in JB-4
embedding solution and sectioned using Leica RM2265 Rotary
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described previously (Topczewska et al., 2001). Monoclonal Anti-Titin
(Mouse) and Anti-Laminin (Rabbit) primary antibodies were pur-
chased from Sigma®. Znp1 was obtained from the Developmental
Studies Hybridoma Bank. TG(ﬂk1:GFP)/TG(ﬂi1:GFP) embryos were
mounted laterally in 2%methylcellulose in glass bottom culture dishes
(MatTek). The images were acquired using a Zeiss LSM 510 laser
scanning inverted confocal microscope.
Morpholino oligonucleotides and microinjections
Three antisense morpholino oligonucleotides (MOs) (Gene Tools),
MO1-pld1 (5′-CCAGGTTCTCCACCGAATCACTCAT-3′), MO2-pld1 (5′-
TGTCTCATCACCTCTTAAGAAAGAG-3′), and MO3-pld1 (5′-GGTCCAT-
CATACAAACCTGCTCTAT-3′), were designed to speciﬁcally target the
ATG start codon and inhibit translation, the intron–exon junction, and
the exon–intron junction of the exon coding the ﬁrst HKD motif
respectively. A 5-mismatch MO (5mismatchMO2-pld1: 5′-TGTCTGAT-
GACCTCTTAACAAACAG-3′) corresponding to HKD1a was also
designed as a control. Indicated dosages of MOs were injected into
the yolk of one to two-cell stage embryos using a pneumatic
picopump (WPI) or Eppendorf FemtoJet. Microinjection was per-
formed as described previously (Zeng et al., 2007).
Transplantation
Genetic mosaic analyses were performed essentially as described
(Yamashita et al., 2002). WT donor embryos were injected with 1%
Rhodamine-dextran (Molecular Probes) at the one-cell stage. pld1
morphant host embryos were generated by injecting 6 ng MO2-pld1
into TG(ﬂi1:GFP) transgenic embryos at the one-cell stage. For
notochord transplantations, between 5.7 and 6 hpf (hours post
fertilization), when the embryonic shield became morphologically
distinct, 30–50 cells from the shield region were aspirated from one
WT donor embryo using a transplantation needle. The group of the
donor cells was immediately transplanted into the shield of a host
embryo. To transplant somitic cells, at the similar stage, 30–50 deep
cells were aspirated from the blastoderm margin next to the shield of
one donor embryo and immediately transplanted into the equivalent
region of a host embryo to ensure that the initial positions of the
donor and host embryos were identical. The host embryos were
analyzed at 2 dpf.
Statistical analysis
Calculations were made in Microsoft Excel. We report mean and
standard error of mean (SEM), and the probability associated with
Student's T-test (with 2-tailed distribution) and two samples of
unequal variance.
Results
Cloning of zebraﬁsh pld1
To clone a zebraﬁsh Pld homolog, the human PLD1 amino acid
sequence was used to search the zebraﬁsh EST and genomic sequence
databases. Four ESTs sharing similarity with human PLD1 gene were
found. The full-length pld1 cDNA was ampliﬁed by using RT-PCR and
5′-RACE (Rapid Ampliﬁcation of cDNA Ends, Clontech), and main-
tained in Gateway® Cloning system (Invitrogen). Multiple sequence
alignments revealed a 64–68% shared identity at the protein level
between zebraﬁsh Pld1 and mammalian PLD1s (hPLD1, rPLD1,
mPLD1) and a 50% shared identity between zebraﬁsh Pld1 and
mammalian PLD2s (hPLD2, rPLD2, mPLD2) (Supplementary Figs. 1A,
C). The phylogenetic tree of Pld1 and PLDs from other species is shown
in Supplemental data (Supplementary Fig. 1B). Similar to mammalianPLDs, Pld1 contains two conserved HxKxxxxD motifs (Supplementary
Fig. 1A, blue dotted rectangles) and also putative interaction sites for
protein kinase C (PKC) and RhoA (Cai and Exton, 2001; Kook and
Exton, 2005) (Supplementary Fig. 1A, the PKC binding site of zebraﬁsh
Pld1 is on 1–314 amino acids region; RhoA binding site is on 859–1010
amino acids region). The C-terminal portion of Pld1 is highly similar to
mammalian PLD1, with more variation occurring in the N-terminal
portion and the loop region of the protein. A 20-amino acid insertion
at the extreme N-terminal region of mammalian PLD1 is absent in
Pld1 (Supplementary Fig. 1A).
We subsequently performed biochemical assays to compare
activity of zebraﬁsh Pld1 with the human enzyme. Similar to hPLD1,
zebraﬁsh Pld1 exhibited a low basal activity when expressed in the
HEK293 TREx cells and it was robustly stimulated by phorbol ester
(PMA), which is widely used as an activator of PKC and PLD catalytic
activities (Fig.1A). Amutation K898R in human PLD1 HKD domain has
been shown to produce a catalytically inactive protein (Sung et al.,
1997). Likewise, an HKD-mutant construct harboring a corresponding
mutation K846R in the zebraﬁsh Pld1 lacked activity in this assay
(Fig. 1A). To further characterize the biochemical regulation of pld1
gene product, we next performed in vitro PLD activity assays testing
whether its activation is regulated by PKC and small GTPases, as
reported for themammalian enzymes (Brown et al., 1993; Colley et al.,
1997; Singer et al., 1996). These assays demonstrated that zebraﬁsh
Pld1, similar to mammalian PLD1 enzymes, can be activated by both
PKCα and Arf1 (Fig.1B). The combination of PKCα and Arf1 resulted in
an additive activation of wild-type Pld1. In contrast, both human
K898R and zebraﬁsh K846R mutants did not reveal additional activity
beyond that exhibited by the endogenous PLD in the control HEK293
cells transformed with the empty vector (Fig. 1B). The western blot in
Fig.1C indicates the relative amounts of wild-type GFP-Pld1/PLD1 and
mutated GFP-Pld1/PLD1 that were used in the activity assays. Taken
together, these cell culture and in vitro data demonstrate that the
zebraﬁsh pld1 gene encodes a bona ﬁde Pld1.
The dynamic expression pattern of pld1 during early
zebraﬁsh development
Using RT-PCR, we detected pld1 transcripts in 4-cell stage (1 hpf)
embryos (Supplementary Fig. 2), before the onset of the zygotic
transcription, thus indicating a maternal RNA deposition. The
abundance of pld1 RNA decreased by 5 hpf and started to increase at
the end of the gastrula period (9 hpf; Supplementary Fig. 2 and data
not shown). A strong pld1 expression was detected in 26 hpf embryos
(Supplementary Fig. 2). The spatio-temporal expression pattern of
pld1 during zebraﬁsh development was analyzed by whole mount in
situ hybridization (Thisse et al., 1993). In a 16-cell stage zebraﬁsh
blastula (1.5 hpf) we observed ubiquitous distribution of pld1
transcripts (Fig. 2A). At the early gastrulation (shield stage; 6 hpf),
pld1 was ubiquitously but very weakly expressed (data not shown).
However, at the 4 somite stage (11.3 hpf), pld1 expression became
clearly detectable again and was restricted to the anterior notochord
and the adjacent forming somites (Figs. 2B, C). At the 12 somite stage
(15 hpf), pld1 expression remained largely conﬁned to the differ-
entiating notochord (Figs. 2D, E) with uneven expression along the
anteroposterior axis in the somites ﬂanking the notochord (Fig. 2D,
arrows). The expression of pld1 in somites became more pronounced
during late segmentation stages (Figs. 2F, G, arrows). The cross-
sections through the trunk region further conﬁrmed that pld1 was
expressed strongly in the somites in the anterior trunk (Fig. 2H) but
remained restricted to the notochord at the posterior trunk (Fig. 2I).
After 1 dpf, pld1 was primarily expressed in the somites (Fig. 2K,
arrows). At 2 dpf, the expression of pld1 became strongly reduced in
the somites (Fig. 2L), and appeared in the pharyngeal pouch tissues
(Fig. 2L). At early larval stages (3 and 4 dpf), pld1 RNA was detected
mainly in the liver (Figs. 2M, N).
Fig. 1. Activation of zebraﬁsh Pld1 in HEK293 cells. Recombinant human PLD1 (hPLD1) or zebraﬁsh Pld1 (zPld1), was transiently expressed in HEK293 cells, and activity was
measured, in vivo (A) and in vitro (B). Cells were transfected with an empty pEGFP-C1 vector, or a vector encoding wild-type hPLD1 (hPLD1 wt), or zPld1 wt. In addition, catalytically
inactive mutants of hPLD1 K989R and zPld1 K846R were transfected. (A) In vivo activity was measured as the transphosphatidylation of radiolabeled endogenous substrate to 1-
butanol, in response to 100 nM PMA compared to basal. (B) In vitro PLD activity wasmeasured using 20mg total cell lysates for either basal or with the following recombinant protein
additions: Arf1 (275 nM), PKCα (1 μM), or Arf1 (275 nM)+PKCα (1 μM) for each transfection condition. Data are expressed as mean±SEM (⁎, pb0.03 when compared to the basal
activity of each transfection) of triplicate samples from three independent experiments. (C) Representative Western blot analysis of the transiently expressed N′-GFP tagged PLD1
proteins (GFP-PLD) or GFP vector control (GFP) used in the PLD activity assay. Equal loading of the protein was standardized by GAPDH.
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morpholino oligonucleotides
To determine the role of Pld1 in zebraﬁsh development, we
employed two strategies to inhibit its function. First, we designed
three antisense morpholino oligonucleotides (MOs) (Fig. 3A) to
speciﬁcally either block pld1 RNA translation or interfere with its
splicing. MO1-pld1 was designed to target the ATG translation
initiation site, whereas MO2-pld1 and MO3-pld1 targeted the
intron–exon boundary and the exon–intron boundary of the exon
encoding the ﬁrst HKDmotif, respectively. A ﬁve-nucleotidemismatch
morpholino (5mismatch MO2-pld1) corresponding to MO2-pld1 was
also designed to serve as a negative control. The effectiveness of MO1-
pld1 in blocking pld1 translation was evaluated by using an in vitro
translation assay, in which various amounts of MO1-pld1 were added
to block the translation of a ﬂag-tagged partial pld1 construct.
Subsequently the protein production was analyzed by western blot
with the anti-ﬂag antibody. We observed that 10 nM, 0.5 μM and 5 μM
MO1-pld1 caused a 34%, 60% and 82% decrease in ﬂag-Pld1 fusion
protein expression, respectively (Fig. 3B). The effectiveness of MO2-
pld1 and MO3-pld1 in interfering with pld1 splicing was evaluated
by RT-PCR ampliﬁcation (Fig. 3C) and by sequencing the resulting pld1
cDNAs (data not shown). As expected, MO2-pld1 caused the retention
of the intron in front of the HKD1 motif-coding exon and introduced a
premature stop codon. Comparing the intensity of the RT-PCR band
from control embryos, an injection of 3 or 6 ng of MO2-pld1 perembryo caused the production of a incorrectly splicedmRNA (58% and
62%) and a 34% or 50% reduction in native pld1 mRNA. By contrast,
injections of 8 ng of 5mismatch MO2-pld1 per embryo did not cause a
mis-splicing event. Similar analyses revealed that the injections of
MO3-pld1 caused the retention of the intron after the HKD1 motif-
coding exon to introduce a stop codon, as corroborated by sequencing
of the respective cDNAs. An injection of 3 or 6 ng MO3-pld1 per
embryo caused the production of a mis-spliced mRNA and an 88% or
98% reduction in the native pld1 mRNA. Notably, co-injections of
MO2-pld1 andMO3-pld1 resulted in a more efﬁcient interference with
the pld1 splicing: only 1% of the native pld1mRNAwas detected in the
embryos injected with 3 or 6 ng of each MO2-pld1 and MO3-pld1.
We sought to measure the PLD activity in zebraﬁsh using an
advanced stable isotope mass spectrometry (MS)-based assay that
allowed assessment of enzyme activity in the whole embryo. We
conducted this MS-based lipid analysis to speciﬁcally measure the
Pld1 activity in homogenates of untreated embryos at 1 dpf using a
stable isotope precursor methodology (Brown et al., 2007). In the
spectra of PMA+1-butanol (1-BuOH) treated samples, three peaks
increased (Supplementary Fig. 3): 34:1 phosphatidylbutanol
(PtdBuOH) at m/z 729, 34:2 PtdBuOH at m/z 727, and 38:6 PtdBuOH
at m/z 775. In the PMA+1-BuOH-d10 treated samples, all of the
PtdBuOH peaks shifted 9 Da, conﬁrming their identity as PtdBuOH-d9,
the product of PLD activity. The unambiguous identiﬁcation of
PtdBuOH species (resulting from the PMA+1-BuOH treatment)
was accomplished by tandem mass spectrometry (MS/MS). The
Fig. 2. Spatio-temporal expression of pld1 during zebraﬁsh embryogenesis. (A) pld1 transcripts are ubiquitously distributed at 16-cell stage (1.5 hpf). At 11.3 hpf (B, C) and 15 hpf
(D, E), pld1 expression is restricted to the dorsal notochord (nc) and the adjacent forming somites (sm). (F–I) pld1 expression in somites (sm) becomes more pronounced during late
segmentation stages. (H, I) Cross section of an embryo at 21.5 hpf shows pld1 expression in the somites (sm) in the anterior trunk region (H) but in notochord (nc) in the posterior
trunk (I). (J, K) At 24 hpf, pld1 is primarily expressed in the somites (sm). (L) At 2 dpf, the expression of pld1 is strongly reduced in the somites and appears in the pharyngeal
pouch (pp). (M, N) At 3 dpf and 4 dpf, pld1 is detected mainly in the liver. (A) Animal view: (B, D) dorsal views, animal pole towards the top; (C,E,F,K,L,M) lateral views, anterior to
the left; (G, N) dorsal view, anterior to the left. Animal pole (☆,★). Vegetal pole (#). Dorsal (D). Scale bar represents 100 μm (H, J) and 250 μm (A, C, E, F, K, L).
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Supplementary Figs. 4A–G. Panel A of Fig. S4 shows the MS/MS
spectrum of the peak atm/z 729. A detailed description of the product
ions used to identify the fatty acyl components is provided in the
Supplementary data. This advanced analytical methodology provides
a quantitative analysis of changes in Pld product formation and a
precise molecular signature for this enzyme activity in zebraﬁsh
embryos.
Next we sought to determine whether any systematic changes in
Pld activity occurred following the decreased expression resulting
from MOs injections. Using mass spectrometry we were able to
quantify changes in enzyme activity in the whole embryo. The Pld1
activity in the uninjected control andMO1-pld1 injected zebraﬁshwas
also measured by MS (Supplementary Fig. 5). Pld1 activity was
signiﬁcantly impaired by injecting MO1-pld1 (50 embryos were used
for 1 sample). In the spectra of PMA+1-BuOH-d10 treated uninjected
embryos, three PtdBuOH peaks were observed: 34:1 PtdBuOH-d9 at
m/z 738, 34:2 PtdBuOH-d9 at m/z 736, and 38:6 PtdBuOH-d9 at m/z
784. In the PMA+1-BuOH-d10 treated Pld1 morphant samples, the
intensity of PtdBuOH peaks decreased. The results of this extensiveMS
analysis are integrated and presented in Fig. 3D. Together these
several lines of evidence demonstrated that injections of MOstargeting pld1 translation or splicing resulted in a signiﬁcant reduction
of its expression and activity.
Loss of Pld1 function results in vascular defects
The pld1morphant embryos underwent the early cleavages during
blastula stages and exhibited normal morphogenesis during gastrula-
tion (data not shown). However, at 24 hpf, most of pld1 morphants
exhibited little or no circulation and developed pericardiac edema.
This phenotype prompted us to investigate the heart and the vascular
system development. However, no obvious abnormalities in morphol-
ogy and heart beat were detected (data not shown). In addition, we
monitored the myocardium and endocardium development of pld1
morphants in embryos harboring either TG(ﬂk1:GFP) (Cross et al.,
2003) or TG(cmcl2:GFP) transgene (Burns et al., 2005; Huang et al.,
2003), and no cardiac defects were observed (data not shown).
Compared to wild-type TG(ﬂk1:GFP) embryos (3/3) (Supplementary
Fig. 6C), MO2-pld1 (6 ng) injected embryos (4/4) (Supplementary Fig.
6D) form the major cranial vessels of the head normally. However, the
CCtAs (Cerebellar central arteries) (white arrows) and the retinal IOC
vessels (Inner optic circle) (white dotted circle) are disorganized. In
the axial trunk vasculature of control TG(ﬂk1:GFP/gata1:DsRed)
Fig. 3. Design and evaluation of effectiveness of antisense oligonucleotides targeting pld1 translation and splicing. (A) The scheme of morpholinos designed to target pld1. (B) in vitro
transcription and translation experiment testing the efﬁciency of MO1-pld1 to inhibit pld1 translation in a dose-dependent manner. (C) Gel electrophoresis of RT-PCR ampliﬁed pld1
fragments to monitor interference by MO2-pld1 and MO3-pld1 compared to the normal splicing of pld1. ef1a is used as a loading control. 5mmMO2-pld1: 5mismatch MO2-pld1. (D)
The basal and PMA stimulated PLD activity were measured using a stable isotope method for detecting the formation of PtdBuOH by mass spectrometry. Enzyme activity is
signiﬁcantly reduced in MO1-pld1 injected embryos (⁎, pb0.01). Data is from three independent experiments. Each condition represents the average measurement from 50 embryos
at 1 dpf. Error bars depict SEM.
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normal formation of the caudal vein (CV) — the plexus-like venous
network posterior to the yolk extension and normal red blood cell
circulation. Similarly, 0.3% 1-BuOH treated embryos (Supplementary
Fig. 6B) exhibited a largely normal CV plexus. However, this structure
was slightly less complex than that of control embryos and both the
axial vessels and the ISV contained fewer red blood cells. We observed
similar phenotypes in MO1/MO2-pld1-injected embryos (Fig. 4D′ and
data not shown). Importantly, the expression of gata1, a red blood cell
marker, was strongly affected in pld1 morphants at an earlierFig. 4. Disruption of Pld1 signaling impairs development of intersegmental vessels. (A–F) No
(A, A′) Uninjected control embryos, (B, B′) embryos injected with 8 ng 5mismatch MO2-pld1
t-butanol treated embryo and (F, F′) to 0.3% 1-butanol treated embryo. (A′, B′, E′) Green arr
defects, where ISVs stop in the middle along the ventral–dorsal axis or show completely block
250 μm (A). (G) A bar graph shows the percentage of ISV defects in embryos that were injecte
well as the number of experimental repeats (in parentheses).developmental stage (Supplementary Figs. 6E–H). Given that pld1
morphants/1-BuOH treated embryos also exhibited edema and
slower heart beat, it is likely that the reduced circulation observed
in these animals is due to the combined effects of having a reduced
number of red blood cells and a diminished heart output, which likely
affects both vascular lumenization and blood cell distribution. Most
interestingly, our continued examination of vascular development in
pld1 morphants by visualizing an endogenous alkaline phosphatase
activity (Habeck et al., 2002) revealed defects in the intersegmental
vessels (ISVs) (data not shown). ISVs, which form trunk vascularmarski and (A–F′) ﬂuorescent images of trunk region of TG(ﬂi1:GFP) embryos at 2 dpf.
and (C, C′) embryos injected with 6 ng MO2-pld1, or (D, D′) 4 ng MO1-pld1, (E, E′) 0.3%
ows point to ISVs with normal morphology, whereas (C′, D′, F′) red arrows point to ISV
ed sprouting from the ventral blood vessels (D′, F′). Scale bar represents 20 μm (A′) and
dwith different morpholinos. The total number of embryos is indicated above the bar as
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Fig. 5. Pld1 signaling is required for ISV development at different developmental stages.
The percentage of embryos showing ISV defects after either 0.3% 1-butanol (1-BuOH,
black bars) or 0.3% t-butanol (t-BuOH, hatched bars) treatment during different time
periods of development. Error bars depict standard deviation.
370 X.-X.I. Zeng et al. / Developmental Biology 328 (2009) 363–376network by linking the dorsal aorta or the posterior caudal vein (PCV)
with the dorsal longitudinal anastomotic vessels, are thought to
develop through the process of angiogenesis (Childs et al., 2002;
Isogai et al., 2003). To analyze further this ISV associated phenotype,
we injected either MO1-pld1, MO2-pld1, MO3-pld1 (data not shown)
or 5mismatch control MO2-pld1 into TG(ﬂk1:GFP) (data not shown)
or TG(ﬂi1:GFP) zebraﬁsh embryos at 1-cell stage and monitored the
development of ISVs (Fig. 4). Compared to control siblings (Fig. 4A),
normal ISV development was also observed in 5mismatch MO1-pld1
injected embryos (Fig. 4B) at 1 dpf (data not shown) and 2 dpf (Figs.
4A′, B′, green arrows). By contrast, embryos injected with either 6 ng
MO2-pld1 (Fig. 4C) or 4 ngMO1-pld1 (Fig. 4D) exhibited defects of the
dorsal outgrowth of ISVs or mispatterning of ISVs with a high
frequency (Fig. 4C′, 79%, n=266; Fig. 4D′, 87%, n=225; Fig. 4G),
respectively. BothMO1-pld1 and the MO2-pld1 caused ISV defects in a
dose-dependent manner. Injections of MO1-pld1 at a 2 ng dosage and
of MO2-pld1 at a 3 ng dosage produced ISV defects with a frequency of
33% (n=216) and 35% (n=160), respectively. Whereas co-injections
of these amounts of the two MOs resulted in ISV defects at 67%
(n=98) (Fig. 4G). As a negative control, the 5mismatch MO2-pld1 at
an 8 ng dosage caused only infrequent ISV defects (14%, n=84), in
comparison with the spontaneous defects (7%, n=437) observed in
uninjected control embryos (Fig. 4G). These results demonstrate that
the inhibition of Pld1 function impairs ISV development.
1-butanol treatment phenocopies the ISV defects of pld1 morphants
In the presence of low concentrations of primary alcohols such as
ethanol, 1-butanol or glycerol, PLD catalyzes a transphosphatidylation
reaction to produce the corresponding phosphatidylalcohol at the
expense of phosphatidic acid production. In the case of 1-butanol,
PtdBuOH, the phosphatidylalcohol generated by the transphosphati-
dylation reaction, is a lipid not normally present in cells and therefore
not readily metabolized. Thus, 1-butanol has been widely used to
block PLD signaling by diverting phosphatidic acid production to
PtdBuOH, while tertiary(t) butanol, a non-primary alcohol that cannot
be used in the transphosphatidylation reaction, was used as a control
for general toxicity. To test whether blocking PLD signaling with 1-
butanol has similar effects on zebraﬁsh vascular development, we
incubated zebraﬁsh embryos with 0.3% 1-butanol or t-butanol, as a
negative control, between 12 and 24 hpf, which is the window of ISV
development (Childs et al., 2002; Isogai et al., 2003). Embryos treated
with 1-butanol were slightly shorter, developed pericardiac edema
and exhibited blood accumulation in the trunk and around the yolk
(Fig. 4F; 98%, n=161). In contrast, no obvious defect was observed in
t-butanol treated embryos (Fig. 4E; 5%, n=123) over similar time
courses. To determine the effect of Pld signaling blockage on the
vascular development, TG(ﬂk1:GFP) (data not shown) or TG(ﬂi1:GFP)
(Figs. 4E′, F′) zebraﬁsh embryos were treated with 1-butanol (Fig. 4F′)
or t-butanol (Fig. 4E′) between 12 and 24 hpf and the vascular
development was examined by ﬂuorescence microscopy. Indeed, 1-
butanol treated embryos exhibited very similar ISV defects (Fig. 4F′,
red arrows, 96%, n=317) to those described above for pld1morphants
(Figs. 4C′, D′). By contrast, normal ISV development was observed in t-
butanol treated embryos (Fig. 4E′, green arrows; 95%, n=123). To
characterize in more detail the ISV defect in pld1 morphants or 1-
butanol treated embryos, we tested the expression of tie1 and ﬂk1,
two endothelial marker genes (Fouquet et al., 1997; Lyons et al., 1998).
Consistent with the ISV phenotype found in TG(ﬂk1:GFP)/TG(ﬂi1:GFP)
zebraﬁsh, we observed either the absence of both tie1 and ﬂk1
positive ISVs or expression of tie1 and ﬂk1 marking shortened
sprouting ISVs in either MO1-pld1/MO2-pld1 injected or 1-butanol
treated embryos (Figs. 6A, B, red arrows).
Since the inhibition of PA formation and subsequent lipid signaling
by 1-butanol can be released by washing it out in the medium, we
applied 1-butanol or t-butanol to TG(ﬂk1:GFP) zebraﬁsh embryos atcertain time periods to start to determine the critical time window of
Pld signaling in ISV development.When embryos were treatedwith 1-
butanol between 12 and 24 hpf or 12 and 19 hpf, ISV defects were
detected in 94% or 55% of total 317 or 153 embryos at 3 dpf,
respectively (Fig. 5). Since the primary ISVs do not sprout from dorsal
aorta until around 20 hpf (Childs et al., 2002; Isogai et al., 2003), the
signiﬁcant fraction of embryos with ISV defects in the population of
embryos treated between 12 and 19 hpf (Fig. 5) suggests that the
disruption of Pld1 signaling inhibited the initial migration of ISV
endothelial cells along dorsal aorta and/or sprouting from the dorsal
aorta. The higher percentage of affected embryos in the population
treated between 12 and 24 hpf (Fig. 5) indicates that Pld1 signaling
inhibition also interfered with the continued dorsal migration of ISV
endothelial cells. When embryos were treated with 1-butanol
between 18 and 24 hpf, the growth of ISVs was temporally arrested
and then continued when 1-butanol was washed out (Fig. 5 and data
not shown). No signiﬁcant ISV defect was detected when 1-butanol
was applied at 3 dpf (Fig. 5). However, when embryos were treated
with 1-butanol between 24 and 48 hpf, 47% of them showed the ISV
defect (Fig. 5, n=170), in which the dorsally directed sprouting of ISV
was arrested at the level of horizontal myoseptum at 3 dpf (data not
shown). We interpret these results to mean that Pld1 signal is also
required for the growth of ISV toward the dorsal halves of the trunk
somites. As a control, when embryos were treated with the same
concentration of t-butanol in equivalent time windows, no signiﬁcant
ISV defect was observed (Fig. 5, n=1069). These results indicate that
Pld1 signaling is required for both the initial sprouting and the
continued dorsal growth of ISVs, whereas this time-course experi-
ment analyzes only sensitivity of the end-point of ISV development to
different 1-butanol exposure.
The effect of inhibiting Pld1 signaling on tissues neighboring ISVs
Next we explored the mechanism via which Pld1 deﬁciency
impairs ISV development. Given pld1 expression in developing
somites and notochord at the time of ISV morphogenesis (Fig. 2), it
is noteworthy that proper segmentation and somite boundary
stabilization are required for normal ISV guidance (Shaw et al.,
2006). Hence we monitored somite formation and differentiation in
pld1 morphants and 1-butanol treated embryos. Similar to control
embryos in which muscle ﬁbers were visualized with phalloidin
staining at 1 dpf, the somites of pld1morphants and 1-butanol treated
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the somitic boundary formation was found in pld1 morphants and 1-
butanol treated embryos (data not shown). The development of slow
muscle ﬁbers (F59 antibody) (Fig. 6C, n=12; and data not shown in
1-butanol treatment) and muscle cell differentiation (the sarcomeric
organization of Titin) were also relatively normal (Fig. 6D, n=9; and
data not shown in 1-butanol treatment). Recent studies have also
shown that Laminins, the major constituents of the basement
membrane, are involved in notochord differentiation and ISV devel-
opment (Pollard et al., 2006). Our examination of Laminin1 expres-
sion in the trunk region suggested that it is not signiﬁcantly affected
when Pld1 activity is disrupted (Fig. 6E, n=12; and data not shown in
1-butanol treatment). Thus, the ISV defect in Pld1 signaling deﬁcient
embryos is unlikely to be related to abnormal segmentation, or somite
development. According to a previous report, in some mutants, ISV
defects are also associated with impaired notochord differentiation,
manifest by persistent expression of the early chordamesoderm
markers at 1 dpf (Pollard et al., 2006). However, our analysis of the
early chordamesoderm marker shh showed that it was normally
downregulated in pld1morphants or 1-butanol treated embryos (dataFig. 6. Effect of Pld1 deﬁciency on ISV and surrounding tissue development. (A, B) Loss o
expression of tie1 (A) and ﬂk1 (B) at 30 hpf in the trunk region of uninjected control embryo
arrows indicate stunted ISVs. (C–E) Somite muscle and notochord development is relativel
whole-mount immunohistochemistry show the morphology of somites, slowmuscle and no
antibody was used to stain slowmuscle Myosin. (D) Titin antibody was used to label the orga
notochord region in control sibling and pld1 morphants embryos. Scale bar represents 10 μnot shown), suggesting that notochord differentiation was not
affected when Pld1 function was disrupted.
PLD1 has been recently reported to promote myogenic differentia-
tion in tissue culture (Yoon and Chen, 2008). VEGF and semaphorin
are two angiogenic factors expressed in differentiating somites
(Halloran et al., 1998; Liang et al., 1998; Shoji et al., 2003). However,
our whole mount in situ hybridization analyses of the expression of
genes encoding VEGF and semaphorins 3a1, 3a2, and 3E in pld1
morphants and 1-butanol treated embryos found no signiﬁcant
changes in their expression pattern or levels (data not shown). This
suggests that Pld1 may regulate the ISV development through a
parallel pathway controlling angiogenesis or play a role downstream
of these angiogenic pathways.
Inhibition of Pld1 function does not strongly impair the dorsal–ventral
guidance of primary/secondary motor axons
Current studies have shown that blood vessel and axon guidance
share common molecular mechanisms (Bedell et al., 2005; Carmeliet
and Tessier-Lavigne, 2005; Lee et al., 2002; Lu et al., 2004; Torres-f Pld1 function impairs ISV development. Whole mount in situ hybridization showing
s, and embryos either injected with MO1-pld1 or treated with 1-butanol (1-BuOH). Red
y normal in embryos with disrupted Pld1 signaling. Representative confocal images of
tochord in MO2-pld1 injected embryos at 2 dpf. Lateral view, anterior to the left. (C) F59
nization of muscle cell “Z-discs”. (E) Laminin immunoreactivity at the myosepta and the
m (D), 20 μm (C, E) and 40 μm (A).
372 X.-X.I. Zeng et al. / Developmental Biology 328 (2009) 363–376Vazquez et al., 2004). In zebraﬁsh, each somitic hemisegment is
innervated by three primary motoneurons; the caudal primary
motoneuron (CaP), the middle primary motoneuron (MiP) and therostral primary motoneuron (RoP). The axons of all three motoneur-
ons exit from the spinal cord, and extend ventrally along a common
pathway and reach a choice point, the horizontal myoseptum region.
373X.-X.I. Zeng et al. / Developmental Biology 328 (2009) 363–376After pausing at the choice point, the pathways of the axons diverge in
the following manner: CaP extends ventrally along the ventromedial
myotome; MiP grows dorsally along the dorsalmedial myotome; and
RoP extends laterally through the horizontal myoseptum (Beattie et
al., 2002; Eisen et al., 1986). To determinewhether Pld signaling is also
involved in the guidance of motor neuron axons, we performed
immunohistochemistry using a Znp1 antibody to monitor axon
guidance in TG(ﬂk1:GFP) zebraﬁsh. Although the growth of interseg-
mental vessels was dramatically impaired in either MO1-pld1 (4 ng)
injected or 1-butanol treated embryos, no signiﬁcant defects in
motoneuron axon (CaP) dorsal–ventral outgrowth were observed in
these embryos, compared with control embryos (Fig. 7A). Consistent
with these results, in anti-acetylated tubulin antibody labeled
embryos, no signiﬁcant motor neuron axon guidance defects were
observed in pld1 morphants or 1-butanol treated embryos (TG(ﬂi1:
GFP)) by monitoring the original confocal image stacks (Fig. 7B and
data not shown). We noted however, that these ventrally extending
axons exhibited more branched morphology (Figs. 7A, B, white
arrowheads). These results suggest that Pld1 signaling speciﬁcally
regulates blood vessel growth but not motor neuron axon guidance in
the trunk of zebraﬁsh embryos.
Non-autonomous role of Pld1 in ISV development
In order to test further the speciﬁcity of Pld1 in ISV development,
we undertook two strategies to rescue a normal ISV development in
pld1 morphants. Firstly, our efforts to rescue the ISV defects in pld1
morphants were hampered by the fact that injections of synthetic pld1
RNA caused gastrulation defects (data not shown). In our second
strategy to restore normal Pld1 activity in pld1 morphants and to
identify the tissue source of Pld1 relevant to the ISV development, we
transplanted wild-type cells into pld1 morphant embryos. In these
experiments, we labeled prospective wild-type donor embryos by
injecting Rhodamine-dextran dye at the 1-cell stage. We disrupted
normal Pld1 activity in prospective host embryos by injecting MO2-
pld1 into transgenic ﬂi1:GFP zebraﬁsh embryos (6 ng/embryo). At
the beginning of gastrulation when the Spemann–Mangold organizer
equivalent structure, the embryonic shield becomes visible as a
thickening of the dorsal blastoderm margin, we transplanted a group
of wild-type cells containing Rhodamine-dextran dye from the shield
of the wild-type donor embryos into the equivalent region of MO2-
pld1 injected TG(ﬂi1:GFP) host embryos. Consistent with previous
reports (Miyagi et al., 2004; Saude et al., 2000), some of the
transplanted wild-type cells, were successfully integrated into the
shield, and subsequently contributed to the prechordal plate meso-
derm and the chordamesoderm. Altogether, 15 of the 15 generated
chimeric embryos exhibited Rhodamine-dextran labeled cells in the
prechordal plate derivatives (Fig. 7C), whereas 8 of them had
Rhodamine-dextran labeled cells in both the prechordal plate
mesoderm and notochord (Figs. 7D, E and data not shown). In these
chimeric embryos, we observed a total of 34 segments containing the
transplanted wild-type cells. Using TG(ﬂi1:GFP) to analyze ISVFig. 7. (A, B) Disruption of Pld1 signaling differentially affects ISV and motor axon dorsal–v
znp1 antibody to visualize primary motor neurons (red), which extend from the dorsal to th
the primary and secondarymotor neuron cell body and axons (red) in the trunk region of unin
with MO1-pld1 injection or 1-butanol treatment exhibit impaired ISV morphology compare
ventral side to the dorsal side. Interestingly, the motoneurons are more branched when Pl
Transplanted wild-type cells in the notochord partially rescue the ISV defects in pld1 morp
dextran labeled cells (red) transplanted fromwild-type donor embryos, and localized in the
are visualized in green by TG(ﬂi:GFP). White arrows point to normal ISVs in the regions of the
defective ISVs in segments lacking wild-type cells. (H) In chimeric embryos harboring transp
cells (12%, segments number=34, 8 embryos) compared to segments without wild-type ce
the somites cannot rescue the ISV defects in pld1morphants. (F, G) Fluorescent images of TG(
from wild-type donor embryos, and localized in the somites. Lateral view, anterior to the
defective ISVs in the regions of the chimeric embryos possessing transplanted wild-type cells
type cells. (I) In the chimeras exhibiting transplanted cells in the somites, the percentage of
was comparable to segments without wild-type cells (43%, segments number=92, 9 embrmorphogenesis we observed that only 4 (b12%) of these chimeric
segments were associated with ISV defects (embryo number=8, Fig.
7E, red arrows; data not shown; Fig. 7H), while the remaining wild-
type cells containing segments exhibited relatively normal ISVs (Figs.
7D, E, white arrows). By contrast, 33% of the nonchimeric segments
exhibited ISV defects (embryo number=15, segment number=164;
Figs. 7D, E, red arrows; and Fig. 7H). Given that pld1 is also expressed in
the paraxial mesoderm (Fig. 2), we also carried out experiments in
which paraxial mesoderm cells were transplanted into equivalent
position of morphant embryos. As expected, these transplanted
paraxial cells contributed largely to the somites of the host embryos
(Figs. 7F, G) with a few of them contributing to the ventral spinal cord
(Fig. 7G, white dotted circle) due to proximity of prospective
neuroectodermal cells to themesoendoderm cells at early gastrulation
(Kimmel et al., 1990). Altogether, 9 generated chimeric embryos
exhibited Rhodamine-dextran labeled cells in the paraxial mesoderm
derivatives (Figs. 7F, G). In these chimeric embryos,we observed a total
of 124 segments containing the transplanted wild-type cells. Using TG
(ﬂi1:GFP) to analyze ISV morphogenesis we observed that 64/124
(52%) of these chimeric segmentswere still associatedwith ISVdefects
(embryo number=9, Figs. 7F, G, white arrowswith red ﬁlling; Fig. 7I),
comparable to 43% of the remaining nonchimeric segments with ISV
defects (embryo number=9, segment number=92; Fig. 7F, white
arrows with red ﬁlling; and Fig. 7I). Our transplantation results
demonstrated that by providing Pld1 at the endogenous locations in
morphants could partially rescue the affected ISV development, thus
supporting the speciﬁcity of the observed ISV phenotype. Moreover,
these experiments suggest that Pld1 inﬂuences ISV development in
non-autonomous manner by acting in the notochord tissues.
Discussion
Whereas PLD has been implicated in many cellular processes, its in
vivo function in vertebrates is not clear due to the lack of loss-of-
function studies in the context of vertebrate animal models. Here we
cloned the zebraﬁsh ortholog of PLD1, examined its expression and
function during zebraﬁsh development, and provided evidence that
Pld1 is required for ISV development.
Zebraﬁsh Pld1 shares higher similarity with mammalian PLD1 than
with PLD2 (Supplementary Fig. 1), and our biochemical data shows
that it is regulated by PKCα and Arf (Fig. 1). These observations support
the notion of Pld1 being the ortholog of mammalian PLD1. In fact, an
EST encoding a fragment of the zebraﬁsh Pld2 has been recently
deposited in Genbank, and cloning of the pld2 gene is in progress.
The pld1 gene product displays a dynamic expression pattern
during zebraﬁsh development. Following ubiquitous expression until
late gastrulation, the earliest regionalized expression of pld1 was
detected in notochord of 4 somite-stage embryos (Figs. 2B, C). Strong
pld1 expression in notochord was observed until 18 somite stage (Figs.
2F, G), when it was downregulated in the anterior region and
maintained in the posterior nascent notochord when the expression
in the somites commences.entral morphogenesis. (A) Uninjected control TG(ﬂk1:GFP) embryos were stained with
e ventral side along with ISV (green). (B) Anti-acetylated tubulin antibody detects both
jected control TG(ﬂi1:GFP) embryos, and ISV (green) is positioned in between. Embryos
d with control embryos; however, all the motor neurons are able to connect from the
d1 signaling is disrupted (white arrowheads), compared to control embryos. (C–E, H)
hants. (C–E) Fluorescent images of TG(ﬂi:GFP) pld1 morphants containing Rhodamine-
prechordal plate (C) or anterior notochord (D, E). Lateral view, anterior to the left. ISVs
chimeric embryos possessing transplanted wild-type cells, whereas red arrows indicate
lanted cells in the notochord, the percentage of ISV defects in segments with wild-type
lls (33%, segments number=164, 15 embryos). (F, G, I) Transplanted wild-type cells in
ﬂi:GFP) pld1morphants containing Rhodamine-dextran labeled cells (red) transplanted
left. ISVs are visualized in green by TG(ﬂi:GFP). White arrows with red ﬁlling point to
, whereas red arrows with white ﬁlling indicate defective ISVs in segments lacking wild-
ISV defects in segments with wild-type cells (51%, segments number=124, 9 embryos)
yos). Scale bar represents 20 μm (A) and 30 μm (C–G).
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Pld1 is required for proper ISV sprouting and migration. First, we
observed similar defects in ISV development, absent or stunted ISVs,
in embryos in which Pld1 function was reduced using one MO
designed to interfere with pld1 RNA translation and two MOs
interfering with its splicing (Figs. 3, 4). Second, these defects occurred
in a dose dependent manner (Fig. 4G). Third, ISV defects were not
observed when a control morpholino containing 5 mismatches with
the MO2-pld1 was used (Figs. 4B′, G). The role of Pld1 in ISV
development is further supported by experiments in which Pld1
signaling was blocked using 1-butanol in ﬂk1:GFP/ﬂi1:GFP transgenic
zebraﬁsh and monitoring endothelial marker genes, tie1 and ﬂk1,
expression in morpholino-injected or chemical treated wild-type
embryos (Figs. 4F′, and 6A, B). Importantly, ISV defects were observed
in embryos treated with 1-butanol but not with t-butanol (Fig. 5), a
non-primary alcohol that cannot be used by Pld1 in the transpho-
sphatidylation reaction. Partial suppression of the ISV morphogenetic
defects observed in chimeric pld1 morphant embryos containing
transplanted wild-type cells (Figs. 7C–E, H) provides another strong
evidence that the ISV defects observed in pld1 morphants and 1-
butanol treated embryos reﬂect a speciﬁc role of Pld1 in ISV
development. These several lines of evidence support the notion
that Pld1 plays an important role in regulating ISV morphogenesis.
An important question is to what degree Pld1 function was
reduced in these experiments. We have demonstrated the efﬁciency of
both the translation MO and splicing MOs. The translation MO
signiﬁcantly reduced translation of the Pld1 protein in an in vitro
translation assay (Fig. 3B). Furthermore, the levels of endogenous
transcripts were highly downregulated in embryos injected with MOs
targeting pld1 splicing (Fig. 3C). Importantly, we observed signiﬁcant
downregulation of Pld activity in pld1 morphants and embryos
treated with 1-butanol, using mass spectrum analyses (Fig. 3D and
Supplementary Figs. 3–5). These several lines of evidence indicate that
the observed phenotypic defects reﬂect strong partial loss of Pld1
function. However, it is possible that stronger and/or new defects will
be observed when Pld1 function is completely abolished. Possible
functional redundancies between Pld1 and Pld2 also await future
investigation.
The zebraﬁsh ISV network is formed via a two-step angiogenic
mechanism (Isogai et al., 2003). The primary ISV sprouts emerge
exclusively from the dorsal aorta at about 20 hpf, reach the
dorsolateral roof of the neural tube at about 28 hpf, then branch and
form dorsal longitudinal anastomotic vessel (DLAV) by 1.5 dpf. The
secondary ISVs sprout exclusively from the posterior cardinal vein in a
less synchronous manner after the formation of the primary ISV
network is completed. Some of the secondary sprouts connect to the
base of primary sprouts and become intersegmental veins. Lineage
analyses demonstrated that the endothelial cells forming ISVs are
derived from the lateral posterior mesoderm, migrate along with axial
vessels before ISV sprouting and then dorsally between somites to
their ﬁnal position (Childs et al., 2002). Pathﬁnding for the ISV
ventral–dorsal migration likely involves multiple repulsive and
attractive cues (Bedell et al., 2005; Lee et al., 2002; Lu et al., 2004;
Torres-Vazquez et al., 2004). As ISVs in Pld1-deﬁcient embryos were
either absent or severely shortened, Pld1 is likely required for ISV
sprouting and migration (Figs. 4, 5).
When does Pld1 act to inﬂuence ISV development? Transient
treatments with 1-butanol established two phases of Pld1 require-
ment for ISVmorphogenesis. The ﬁrst one during segmentation stages
(12–19 hpf) and the second at 24–48 hpf, but is no longer required
after 30 hpf (Fig. 5). Despite our 1-butanol time-course experiment
aimed to discover a requirement window of Pld in ISV development, it
will be important in the future to ask whether different exposure
regimens trigger different mechanisms of ISV interruption, e.g. with
earlier exposures affecting the emergence of early arterial sprouts and
later exposure impairing the later-emerging venous sprouts. The factthat during the shorter treatments (12–19 hpf and 18–24 hpf) ISVs
halted their outgrowth but resumed it after removal of 1-butanol
could be interpreted to mean that pld1 acts in ISV development from
12–30 hpf. Interestingly, during segmentation stages to 1 dpf, pld1 is
strongly expressed in mature somites and transiently in the
differentiating notochord. It is known that somites are the source of
a variety of molecules implicated in guidance of blood vessel
morphogenesis, including VEGF, Semaphorins, Netrin and Slits (Lu
et al., 2004; Shoji et al., 2003; Torres-Vazquez et al., 2004). Many
recent publications indicate that axons and blood vessels share similar
guidance mechanisms (Bedell et al., 2005; Carmeliet and Tessier-
Lavigne, 2005; Lee et al., 2002; Lu et al., 2004; Torres-Vazquez et al.,
2004). Although we found an ISV defect in pld1 morphant embryos,
we did not observe any striking defect of the motor axon dorsal–
ventral guidance in Pld1-deﬁcient embryos using Znp1 (Zn8, Zn12 and
anti-acetylated tubulin) antibody staining (Figs. 7A, B and data not
shown). However, we noted more branched morphology of these
motoneurons. This suggests that the Pld1 activity is speciﬁcally
required for blood vessel guidance. Whereas Pld1 appears less
important for dorsal–ventral motor neuron axon guidance, it may
play a role in axonal morphogenesis. In support of this notion, it was
recently reported that PLD1 promotes outgrowth of hippocampal
dentate granule cell axons by enhancing tissue plasminogen release
(Zhang et al., 2005).
The notochord, which produces a variety of secreted signals, plays an
essential role in the patterning of surrounding tissues including blood
vessels, somites, pancreas, and the neural tube (Stemple, 2005). Hence,
it is possible that Pld1 may play some role in tissue patterning and ISV
morphogenesis by regulating the notochord differentiation and/or
production of notochord-derived signals. Consistent with this notion,
some pld1 morphant embryos exhibited curved body axis (Fig. 4D).
However, expression of one of the notochord localized proteins, Laminin
1 involved in ISV development (Pollard et al., 2006), was unaffected in
pld1 deﬁcient embryos (Fig. 6E). That shh expression becomes down-
regulated in the notochord in pld1 morphants on schedule (data not
shown) further suggests that the notochord differentiation is normal.
A critical role of Pld1 for ISV development in the notochord and not
the somites is further supported by the results of our transplantation
experiments, in which presence of wild-type notochord cells in pld1
chimeric morphants, correlated with normal ISV development that has
not been observed in chimeric embryos harboring transplanted wild-
type cells only in the somites. Thus it is tempting to speculate that Pld1 is
required in the notochord for a signal that promotes or guides ISV
morphogenesis. The fact that treatment with 1-butanol can inhibit ISV
formation at a time period (24–48 hpf) when pld1 is not expressed in
the notochord could be due to expression of pld2 in this or different
tissues of zebraﬁsh embryos at this particular time. Another alternative
explanation could be that zebraﬁsh Pld1 protein perdures in the
notochord to fulﬁll its function until this stage of development, even
when pld1 transcripts are no longer detectable. Our in situ hybridization
analyses revealed that the expression pattern or level of endothelial and
blood vessel cell markers (ﬂk1 and tie1) in pld1morphant or 1-butanol
treated embryos were relatively normal, indicating that blood vessel
fates are properly speciﬁed.Moreover,wehave not found anychanges in
expression of several genes encoding molecules (vegf, angiopoietin, se-
maphorin 3a1, 3a2 and 3E, slit1 and slit2) implicated in angiogenesis. It is
possible that the changes in the expression level of these guidance
factors are subtle and in situ hybridization is not sensitive enough to
detect the changes. It is also possible that Pld1 may function
independently or downstream of these or other guidance signals.
Previous studies of another type of phospholipase, phospholipase
C gamma1, revealed its important role in primitive hematopoiesis
during zebraﬁsh development (Ma et al., 2007). Zebraﬁsh
PLCgamma1 was also implicated in arterial development downstream
of VEGF (Lawson et al., 2003). That both phospholipase C gamma1 and
Pld1 are required for different aspects of blood vessel development in
375X.-X.I. Zeng et al. / Developmental Biology 328 (2009) 363–376zebraﬁsh suggests that lipid signaling plays a signiﬁcant role in the
development of the vertebrate vascular system. The distinct require-
ments for these two phospholipases likely reﬂect distinct products
from each unique enzymatic reaction. PLD has previously been
implicated in cell migration. Gomez-Cambronero et al. demonstrated
that PLD plays a key role in leukocyte adhesion and chemotaxis
toward a gradient of chemokines (Gomez-Cambronero et al., 2007).
Similarly, expression of active PLD2 is associated with spreading and
elongation of EL4 cells in a cultured system (Knoepp et al., 2008). PLD
has also been implicated in Dictyostelium discoideum as a gene
involved in cell migration (Nagasaki and Uyeda, 2008). PA is the main
product of the PLD catalyzed reaction and this bioactive lipid is
thought to mediate many of PLD's functions. Delon et al. (2004)
demonstrated that PA binds to sphingosine kinase, which phosphor-
ylates sphingosine to generate sphingosine 1-phosphate (S1P), and
facilitates its translocation to PA-enriched membrane compartments.
S1P, acting through its receptors, was shown to promote blood vessel
formation by regulating endothelial cell migration and survival (Kono
et al., 2004; Osborne and Stainier, 2003). PA can be further converted
to LPA, which activates its G protein coupled receptors. LPA signaling
has been implicated in both cancer cell and endothelial cell migration
(Mills and Moolenaar, 2003; Osborne and Stainier, 2003). Mazie et al.
reported that short-chain analogues of PA induce motility in corneal
and other epithelial cell types (Mazie et al., 2006). Subsequent
metabolism did not appear to be required and although the down-
stream targets were not identiﬁed the authors noted a striking
transactivation of the epidermal growth factor receptor as a possible
mechanism. Thus, it is possible that Pld1 plays a role upstream of S1P
or LPA to regulate angiogenesis.
In summary, we have cloned a zebraﬁsh homolog of pld1 gene and
described its dynamic expression pattern during embryonic develop-
ment.We characterized the regulatory properties and found that it is a
bona ﬁde PLD1 enzyme. Using both loss-of-function and chemical
approaches, we identiﬁed a novel cell non-autonomous role for Pld1
in the regulation of angiogenesis.
Acknowledgments
We thank the members of the Brown and LSK group for their
discussions, Dr. Sarah Childs and Dr. Jesús Torres-Vázquez for the
advice, Dr. Charles Hong for sharing the ﬂi1:GFP zebraﬁsh transgenic
line, Dr. Jesús Torres-Vázquez for sharing the ﬂk1:GFP/gata1:DsRed
zebraﬁsh transgenic line and Dr. Sarah Kucenas in B. Appel lab for
sharing the motoneuron antibodies. We acknowledge the excellent
ﬁsh care by Heidi Beck and other SC Fish Facility Research Assistants.
This workwas partially supported by grants from the National Institutes
of Health (U54 GM69338 to HAB, GM77770 to LSK, and HL073348 to
TPZ) as well as support from the Ingram Cancer Professorship
endowment to HAB and Martha Rivers Ingram endowment to LSK.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.ydbio.2009.01.035.
References
Beattie, C.E., Granato, M., Kuwada, J.Y., 2002. Cellular, genetic and molecular
mechanisms of axonal guidance in the zebraﬁsh. Results Probl. Cell Differ. 40,
252–269.
Bedell, V.M., Yeo, S.Y., Park, K.W., Chung, J., Seth, P., Shivalingappa, V., Zhao, J., Obara, T.,
Sukhatme, V.P., Drummond, I.A., Li, D.Y., Ramchandran, R., 2005. roundabout4 is
essential for angiogenesis in vivo. Proc. Natl. Acad. Sci. U. S. A. 102, 6373–6378.
Brown, H.A., Gutowski, S., Moomaw, C.R., Slaughter, C., Sternweis, P.C., 1993. ADP-
ribosylation factor, a small GTP-dependent regulatory protein, stimulates phos-
pholipase D activity. Cell 75, 1137–1144.
Brown, H.A., Henage, L.G., Preininger, A.M., Xiang, Y., Exton, J.H., 2007. Biochemical
analysis of phospholipase D. Methods Enzymol. 434, 49–87.Buchanan, F.G., McReynolds, M., Couvillon, A., Kam, Y., Holla, V.R., Dubois, R.N., Exton, J.H.,
2005. Requirement of phospholipase D1 activity in H-RasV12-induced transforma-
tion. Proc. Natl. Acad. Sci. U. S. A. 102, 1638–1642.
Burns, C.G., Milan, D.J., Grande, E.J., Rottbauer, W., MacRae, C.A., Fishman, M.C., 2005.
High-throughput assay for small molecules that modulate zebraﬁsh embryonic
heart rate. Nat. Chem. Biol. 1, 263–264.
Cai, S., Exton, J.H., 2001. Determination of interaction sites of phospholipase D1 for
RhoA. Biochem. J. 355, 779–785.
Cai, D., Zhong, M., Wang, R., Netzer, W.J., Shields, D., Zheng, H., Sisodia, S.S., Foster, D.A.,
Gorelick, F.S., Xu, H., Greengard, P., 2006. Phospholipase D1 corrects impaired
betaAPP trafﬁcking and neurite outgrowth in familial Alzheimer's disease-linked
presenilin-1 mutant neurons. Proc. Natl. Acad. Sci. U. S. A. 103, 1936–1940.
Carmeliet, P., Tessier-Lavigne, M., 2005. Commonmechanisms of nerve and blood vessel
wiring. Nature 436, 193–200.
Childs, S., Chen, J.N., Garrity, D.M., Fishman, M.C., 2002. Patterning of angiogenesis in the
zebraﬁsh embryo. Development 129, 973–982.
Colley, W.C., Sung, T.C., Roll, R., Jenco, J., Hammond, S.M., Altshuller, Y., Bar-Sagi, D.,
Morris, A.J., Frohman, M.A., 1997. Phospholipase D2, a distinct phospholipase D
isoformwith novel regulatory properties that provokes cytoskeletal reorganization.
Curr. Biol. 7, 191–201.
Cross, L.M., Cook, M.A., Lin, S., Chen, J.N., Rubinstein, A.L., 2003. Rapid analysis of
angiogenesis drugs in a live ﬂuorescent zebraﬁsh assay. Arterioscler. Thromb. Vasc.
Biol. 23, 911–912.
Delon, C., Manifava, M., Wood, E., Thompson, D., Krugmann, S., Pyne, S., Ktistakis, N.T.,
2004. Sphingosine kinase 1 is an intracellular effector of phosphatidic acid. J. Biol.
Chem. 279, 44763–44774.
Eisen, J.S., Myers, P.Z., Westerﬁeld, M., 1986. Pathway selection by growth cones of
identiﬁed motoneurones in live zebra ﬁsh embryos. Nature 320, 269–271.
Exton, J.H., 2002. Phospholipase D-structure, regulation and function. Rev. Physiol.,
Biochem. Pharmacol. 144, 1–94.
Fouquet, B., Weinstein, B.M., Serluca, F.C., Fishman, M.C., 1997. Vessel patterning in the
embryo of the zebraﬁsh: guidance by notochord. Dev. Biol. 183, 37–48.
Ghosh, S., Moore, S., Bell, R.M., Dush, M., 2003. Functional analysis of a phosphatidic acid
binding domain in human Raf-1 kinase: mutations in the phosphatidate binding
domain lead to tail and trunk abnormalities in developing zebraﬁsh embryos. J. Biol.
Chem. 278, 45690–45696.
Gomez-Cambronero, J., Di Fulvio, M., Knapek, K., 2007. Understanding phospholipase D
(PLD) using leukocytes: PLD involvement in cell adhesion and chemotaxis. J.
Leukoc. Biol. 82, 272–281.
Habeck, H., Odenthal, J., Walderich, B., Maischein, H., Schulte-Merker, S., 2002. Analysis
of a zebraﬁsh VEGF receptor mutant reveals speciﬁc disruption of angiogenesis.
Curr. Biol. 12, 1405–1412.
Halloran,M.C., Severance, S.M., Yee, C.S., Gemza, D.L., Kuwada, J.Y.,1998.Molecular cloning
and expression of two novel zebraﬁsh semaphorins. Mech. Dev. 76, 165–168.
Hammond, S.M., Altshuller, Y.M., Sung, T.C., Rudge, S.A., Rose, K., Engebrecht, J., Morris,
A.J., Frohman, M.A., 1995. Human ADP-ribosylation factor-activated phosphatidyl-
choline-speciﬁc phospholipase D deﬁnes a new and highly conserved gene family.
J. Biol. Chem. 270, 29640–29643.
Henage, L.G., Exton, J.H., Brown, H.A., 2006. Kinetic analysis of a mammalian
Phospholipase D: Kinetic analysis of a mammalian Phospholipase D: Allosteric
modulation by monomeric GTPases, Protein kinase C and polyphosphoinosites.
J. Biol. Chem. 281, 3408–3417.
Huang, C.J., Tu, C.T., Hsiao, C.D., Hsieh, F.J., Tsai, H.J., 2003. Germ-line transmission of a
myocardium-speciﬁc GFP transgene reveals critical regulatory elements in the
cardiac myosin light chain 2 promoter of zebraﬁsh. Dev. Dyn. 228, 30–40.
Isogai, S., Lawson, N.D., Torrealday, S., Horiguchi, M., Weinstein, B.M., 2003. Angiogenic
network formation in the developing vertebrate trunk. Development 130, 5281–5290.
Ivanova, P.T., Milne, S.B., Byrne, M.O., Xiang, Y., Brown, H.A., 2007. Glycerophospholipid
identiﬁcation and quantitation by electrospray ionization mass spectrometry.
Methods Enzymol. 432, 21–57.
Jenkins, G.M., Frohman, M.A., 2005. Phospholipase D: a lipid centric review. Cell. Mol.
Life Sci. 62, 2305–2316.
Kimmel, C.B., Warga, R.M., Schilling, T.F., 1990. Origin and organization of the zebraﬁsh
fate map. Development 108, 581–594.
Kimmel, C.B., Ballard, W.W., Kimmel, S.R., Ullmann, B., Schilling, T.F., 1995. Stages of
embryonic development of the zebraﬁsh. Dev. Dyn. 203, 253–310.
Knoepp, S.M., Chahal, M.S., Xie, Y., Zhang, Z., Brauner, D.J., Hallman, M.A., Robinson, S.A.,
Han, S., Imai, M., Tomlinson, S., Meier, K.E., 2008. Effects of active and inactive
phospholipase D2 on signal transduction, adhesion, migration, invasion, and
metastasis in EL4 lymphoma cells. Mol. Pharmacol. 74, 574–584.
Kono, M., Mi, Y., Liu, Y., Sasaki, T., Allende, M.L., Wu, Y.P., Yamashita, T., Proia, R.L., 2004.
The sphingosine-1-phosphate receptors S1P1, S1P2, and S1P3 function coordinately
during embryonic angiogenesis. J. Biol. Chem. 279, 29367–29373.
Kook, S., Exton, J.H., 2005. Identiﬁcation of interaction sites of protein kinase Calpha on
phospholipase D1. Cell. Signal. 17, 1423–1432.
LaLonde, M.M., Janssens, H., Rosenbaum, E., Choi, S.Y., Gergen, J.P., Colley, N.J., Stark, W.S.,
Frohman, M.A., 2005. Regulation of phototransduction responsiveness and retinal
degeneration bya phospholipase D-generated signaling lipid. J. Cell Biol.169, 471–479.
Lawson, N.D., Weinstein, B.M., 2002. In vivo imaging of embryonic vascular
development using transgenic zebraﬁsh. Dev. Biol. 248, 307–318.
Lawson, N.D., Mugford, J.W., Diamond, B.A., Weinstein, B.M., 2003. Phospholipase C
gamma-1 is required downstream of vascular endothelial growth factor during
arterial development. Genes Dev. 17, 1346–1351.
Lee, P., Goishi, K., Davidson, A.J., Mannix, R., Zon, L., Klagsbrun, M., 2002. Neuropilin-1 is
required for vascular development and is a mediator of VEGF-dependent
angiogenesis in zebraﬁsh. Proc. Natl. Acad. Sci. U. S. A. 99, 10470–10475.
376 X.-X.I. Zeng et al. / Developmental Biology 328 (2009) 363–376Liang, D., Xu, X., Chin, A.J., Balasubramaniyan, N.V., Teo, M.A., Lam, T.J., Weinberg, E.S.,
Ge, R., 1998. Cloning and characterization of vascular endothelial growth factor
(VEGF) from zebraﬁsh, Danio rerio. Biochim. Biophys. Acta 1397, 14–20.
Lu, X., Le Noble, F., Yuan, L., Jiang, Q., De Lafarge, B., Sugiyama, D., Breant, C., Claes, F., De
Smet, F., Thomas, J.L., Autiero, M., Carmeliet, P., Tessier-Lavigne, M., Eichmann, A.,
2004. The netrin receptor UNC5B mediates guidance events controlling morpho-
genesis of the vascular system. Nature 432, 179–186.
Lyons, M.S., Bell, B., Stainier, D., Peters, K.G., 1998. Isolation of the zebraﬁsh homologues
for the tie-1 and tie-2 endothelium-speciﬁc receptor tyrosine kinases. Dev. Dyn.
212, 133–140.
Ma, A.C., Liang, R., Leung, A.Y., 2007. The role of phospholipase C gamma 1 in primitive
hematopoiesis during zebraﬁsh development. Exp. Hematol. 35, 368–373.
Mazie, A.R., Spix, J.K., Block, E.R., Achebe, H.B., Klarlund, J.K., 2006. Epithelial cell
motility is triggered by activation of the EGF receptor through phosphatidic acid
signaling. J. Cell Sci. 119, 1645–1654.
McDermott, M., Wakelam, M.J., Morris, A.J., 2004. Phospholipase D. Biochem. Cell. Biol.
82, 225–253.
Mills, G.B., Moolenaar, W.H., 2003. The emerging role of lysophosphatidic acid in cancer.
Nat. Rev., Cancer 3, 582–591.
Miyagi, C., Yamashita, S., Ohba, Y., Yoshizaki, H., Matsuda, M., Hirano, T., 2004. STAT3
noncell-autonomously controls planar cell polarity during zebraﬁsh convergence
and extension. J. Cell Biol. 166, 975–981.
Morris, A.J., Frohman, M.A., Engebrecht, J., 1997. Measurement of phospholipase D
activity. Anal. Biochem. 252, 1–9.
Nagasaki, A., Uyeda, T.Q., 2008. Screening of genes involved in cell migration in
Dictyostelium. Exp. Cell Res. 314, 1136–1146.
Osborne, N., Stainier, D.Y., 2003. Lipid receptors in cardiovascular development. Annu.
Rev. Physiol. 65, 23–43.
Pollard, S.M., Parsons, M.J., Kamei, M., Kettleborough, R.N., Thomas, K.A., Pham, V.N.,
Bae, M.K., Scott, A., Weinstein, B.M., Stemple, D.L., 2006. Essential and overlapping
roles for laminin alpha chains in notochord and blood vessel formation. Dev. Biol.
289, 64–76.
Saude, L., Woolley, K., Martin, P., Driever, W., Stemple, D.L., 2000. Axis-inducing
activities and cell fates of the zebraﬁsh organizer. Development 127, 3407–3417.
Shaw, K.M., Castranova, D.A., Pham, V.N., Kamei, M., Kidd, K.R., Lo, B.D., Torres-Vasquez,
J., Ruby, A., Weinstein, B.M., 2006. Fused-somites-like mutants exhibit defects in
trunk vessel patterning. Dev. Dyn. 235, 1753–1760.
Shoji, W., Isogai, S., Sato-Maeda, M., Obinata, M., Kuwada, J.Y., 2003. Semaphorin3a1
regulates angioblast migration and vascular development in zebraﬁsh embryos.
Development 130, 3227–3236.Singer, W.D., Brown, H.A., Jiang, X., Sternweis, P.C., 1996. Regulation of phospholipase D
by protein kinase C is synergistic with ADP-ribosylation factor and independent of
protein kinase activity. J. Biol. Chem. 271, 4504–4510.
Solnica-Krezel, L., Schier, A.F., Driever, W., 1994. Efﬁcient recovery of ENU-induced
mutations from the zebraﬁsh germline. Genetics 136, 1401–1420.
Stemple, D.L., 2005. Structure and function of the notochord: an essential organ for
chordate development. Development 132, 2503–2512.
Sung, T.C., Roper, R.L., Zhang, Y., Rudge, S.A., Temel, R., Hammond, S.M., Morris, A.J.,
Moss, B., Engebrecht, J., Frohman, M.A., 1997. Mutagenesis of phospholipase D
deﬁnes a superfamily including a trans-Golgi viral protein required for poxvirus
pathogenicity. EMBO J. 16, 4519–4530.
Thisse, C., Thisse, B., Schilling, T.F., Postlethwait, J.H., 1993. Structure of the zebraﬁsh
snail1 gene and its expression in wild-type, spadetail and no tail mutant embryos.
Development 119, 1203–1215.
Topczewska, J.M., Topczewski, J., Shostak, A., Kume, T., Solnica-Krezel, L., Hogan, B.L.,
2001. The winged helix transcription factor Foxc1a is essential for somitogenesis in
zebraﬁsh. Genes Dev. 15, 2483–2493.
Torres-Vazquez, J., Gitler, A.D., Fraser, S.D., Berk, J.D., Van, N.P., Fishman, M.C., Childs, S.,
Epstein, J.A., Weinstein, B.M., 2004. Semaphorin-plexin signaling guides patterning
of the developing vasculature. Dev. Cell 7, 117–123.
Watanabe, H., Yokozeki, T., Yamazaki, M., Miyazaki, H., Sasaki, T., Maehama, T., Itoh, K.,
Frohman, M.A., Kanaho, Y., 2004. Essential role for phospholipase D2 activation
downstream of ERK MAP kinase in nerve growth factor-stimulated neurite
outgrowth from PC12 cells. J. Biol. Chem. 279, 37870–37877.
Yamashita, S., Miyagi, C., Carmany-Rampey, A., Shimizu, T., Fujii, R., Schier, A.F., Hirano,
T., 2002. Stat3 controls cell movements during zebraﬁsh gastrulation. Dev. Cell 2,
363–375.
Yang, S.F., Freer, S., Benson, A.A., 1967. Transphosphatidylation by phospholipase D. J.
Biol. Chem. 242, 477–484.
Yoon, M.S., Chen, J., 2008. PLD regulates myoblast differentiation through the mTOR-
IGF2 pathway. J. Cell Sci. 121, 282–289.
Zeng, X.X., Wilm, T.P., Sepich, D.S., Solnica-Krezel, L., 2007. Apelin and its receptor
control heart ﬁeld formation during zebraﬁsh gastrulation. Dev. Cell 12,
391–402.
Zhang, Y., Kanaho, Y., Frohman, M.A., Tsirka, S.E., 2005. Phospholipase D1-promoted
release of tissue plasminogen activator facilitates neurite outgrowth. J. Neurosci. 25,
1797–1805.
Zhao, C., Du, G., Skowronek, K., Frohman, M.A., Bar-Sagi, D., 2007. Phospholipase D2-
generated phosphatidic acid couples EGFR stimulation to Ras activation by Sos. Nat.
Cell Biol. 9, 706–712.
